נימביו

NimBio is developing an AI-based disease management platform that aims to prevent flare ups and reduce patient readmissions. It provides patients with a non-invasive wearable device that provides continuous measurements of inflammatory biomarkers and accordingly improves IMIDs care.

Healthcare systems and providers, pharmaceutical companies, medical devices market, patients with chronic inflammatory conditions

Tal Atarot - CEO & Founder